Youguang Zheng, Ming Zheng, Yi Liu, Yunsheng Xue, Ling Zhang, Lin An, Ling Liu and Min Ji Pages 340 - 350 ( 11 )
Two series of novel phenylaminopyrimidine derivatives were designed and synthesized. All target compounds were determined against the human acute monocytic leukemia cell line U937 and the human chronic myeloid leukemia cell line K562 in vitro. Some of the target compounds demonstrated significant inhibitory activity against both cell lines. Compared with the control drug VX-680, 8a, 8e, 8g, 8h, 8j, and 8k demonstrated more potent antitumor activity. The structures of all target compounds were identified by 1H-NMR, 13C-NMR, IR, MS, and EA.
Phenylaminopyrimidine derivatives, U937, K562, antitumor activity, Leukemia, clinical trials, Oxidation, benzenes, cancer cell, acetic acid
School of Chemistry & Chemical Engineering, Southeast University, Nanjing 211189, China.